{"id":"W4353086861","doi":"10.54097/hset.v36i.6170","title":"Aducanumab - a potential pharmacological therapeutic treatments for Alzheimer’s disease","year":2023,"lang":"en","type":"article","venue":"Highlights in Science Engineering and Technology","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"The Scarborough Hospital; University of Toronto","funders":"","keywords":"Rivastigmine; Dementia; Disease; Medicine; Clinical trial; Alzheimer's disease; Donepezil; Drug; Mechanism (biology); Psychiatry; Intensive care medicine; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002297672,0.0003809077,0.0003999195,0.0007144296,0.0003341311,0.0006025143,0.0003134529,0.0005780975,0.004496369],"category_scores_gemma":[0.0001894981,0.0001120207,0.0004258931,0.0003275484,0.0002591691,0.0007658825,0.0004197043,0.001298678,0.001270529],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003467521,"about_ca_system_score_gemma":0.0003732604,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003309021,"about_ca_topic_score_gemma":0.0008721041,"domain_scores_codex":[0.9999105,0.00001979344,0.000008994285,0.00001654269,0.0000272321,0.00001707616],"domain_scores_gemma":[0.9999532,0.00000893351,0.000008654833,0.000002640826,0.00001528886,0.00001134621],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006677806,0.0004903383,0.0008169587,0.006331894,0.00009612277,0.001389291,0.0002337494,0.0004017522,0.1023063,0.01164535,0.02126601,0.8543543],"study_design_scores_gemma":[0.0002578015,0.002026153,0.003328624,0.001059478,0.0001930866,0.005841687,0.0001295064,0.0005617207,0.04551743,0.004851948,0.9361759,0.0000567384],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02427723,0.9464661,0.00306062,0.004219171,0.00147554,0.0001270773,0.0002881139,0.0001760411,0.01991013],"genre_scores_gemma":[0.1900155,0.7719555,0.006047371,0.003166232,0.001628299,0.0001665266,0.0005285409,0.00003324162,0.0264587],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004496369,"threshold_uncertainty_score":0.01504183,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03264369329686387,"score_gpt":0.3257592312524021,"score_spread":0.2931155379555382,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}